Adaptive immune responses to SARS-CoV-2

Adv Drug Deliv Rev. 2021 May:172:1-8. doi: 10.1016/j.addr.2021.02.009. Epub 2021 Feb 18.

Abstract

This review focuses on adaptive immune responses against SARS-CoV-2, the coronavirus that causes COVID-19. A great deal of work has been accomplished in a very short period of time to describe adaptive immune responses and to ascertain their roles in determining the course of infection. As with other viral infections, SARS-CoV-2 elicits both antibody and T-cell responses. Whereas antibody responses are likely effective in preventing infection and may participate in controlling infection once established, it is less clear whether or not they play a role in pathogenesis. T cells are likely involved in controlling established infection, but a pathogenic role is also possible. Longer term evaluation is necessary to determine the durability of protective immune responses.

Keywords: Antibody; Epitopes; Immunity; Neutralization; SARS-CoV-2; T cells.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity / immunology*
  • Animals
  • Antibodies, Viral / immunology
  • COVID-19 / immunology*
  • COVID-19 / therapy
  • Humans
  • SARS-CoV-2 / immunology*
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Viral